Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

CDC: Don’t vape, especially THC

Key clinical point: The exact cause of EVALI remains unknown.

Major finding: THC-containing product use was reported by 92% of patients during the 3 months preceding illness.

Study details: Interview of 53/83 EVALI patients in Utah Aug.-Oct. 2019.

Disclosures: The authors reported that they had no conflicts.